Enrolling by invitationNCT07511660
Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY)
Studying Congenital Malformation Syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Healing Hope International
- Principal Investigator
- Dr. Jonatha Leicher, MD: Regenerative MedicineHealing Hope International
- Enrollment
- 12 target
- Eligibility
- 28-70 years · FEMALE
- Timeline
- 2026 – 2030
Study locations (1)
- Stem Solutions, Monterrey, Nuevo León, Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07511660 on ClinicalTrials.govOther trials for Congenital Malformation Syndrome
Additional recruiting or active studies for the same condition.